CoChat
Sign Up
Cited by 103

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Hemoglobinopathies: slicing the gordian knot of plasmodium falciparum malaria pathogenesis.

Taylor, Steve M., Cerami, Carla, Fairhurst, Rick M.·2013·PLoS Pathogens
DOI 10.1371/journal.ppat.1003327PMC PMC3656091
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1003327

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 General mechanisms by which hemoglobinopathies may attenuate the pathogenesis of falciparum malaria. (A) Restriction of red blood cell (RBC) invasion or intraerythrocytic growth, thereby suppressing parasite densities in vivo; (B) interference with parasite-derived mediators of pathogenesis, including those involved in the binding of parasite-infected RBCs (iRBCs) to extracellular host receptors; (C) modulation of innate host defenses to favor protective, anti-inflammatory responses over those that drive pathogenic, pro-inflammatory responses; (D) enhancement of adaptive cell-mediated and humoral immune responses that clear iRBCs from the blood.
Figure 1 General mechanisms by which hemoglobinopathies may attenuate the pathogenesis of falciparum malaria. (A) Restriction of red blood cell (RBC) invasion or intraerythrocytic growth, thereby suppressing parasite densities in vivo; (B) interference with parasite-derived mediators of pathogenesis, including those involved in the binding of parasite-infected RBCs (iRBCs) to extracellular host receptors; (C) modulation of innate host defenses to favor protective, anti-inflammatory responses over those that drive pathogenic, pro-inflammatory responses; (D) enhancement of adaptive cell-mediated and humoral immune responses that clear iRBCs from the blood.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 105

  1. Yenne B (2010) Alexander the Great: lessons from history's undefeated general. New York: Palgrave Macmillan.
  2. P Bejon, 2008, Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age, N Engl J Med, 359, 2521, 10.1056/NEJMoa0807381 · DOI
  3. WP O'Meara, 2008, Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya, Lancet, 372, 1555, 10.1016/S0140-6736(08)61655-4 · DOI · Paper page
  4. LH Miller, 2002, The pathogenic basis of malaria, Nature, 415, 673, 10.1038/415673a · DOI
  5. Amaratunga C, Lopera-Mesa TM, Tse JG, Mita-Mendoza NK, Fairhurst RM (2010) In:Kaufmann S, Rouse B, Sacks D, editor. Immunology of infectious diseases. Washington, DC: American Society of Microbiology Press.
  6. SM Taylor, 2012, Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis, Lancet Infect Dis, 12, 457, 10.1016/S1473-3099(12)70055-5 · DOI · Paper page
  7. JB Haldane, 1949, The rate of mutation of human genes, Hereditas, 35, 267, 10.1111/j.1601-5223.1949.tb03339.x · DOI
  8. DJ Weatherall, 2000, Red cells I: inherited anaemias, Lancet, 355, 1169, 10.1016/S0140-6736(00)02073-0 · DOI
  9. W Trager, 1976, Human malaria parasites in continuous culture, Science, 193, 673, 10.1126/science.781840 · DOI
  10. JD Haynes, 1976, Culture of human malaria parasites Plasmodium falciparum, Nature, 263, 767, 10.1038/263767a0 · DOI
  11. A Bunyaratvej, 1992, Reduced deformability of thalassemic erythrocytes and erythrocytes with abnormal hemoglobins and relation with susceptibility to Plasmodium falciparum invasion, Blood, 79, 2460, 10.1182/blood.V79.9.2460.2460 · DOI
  12. TC Ifediba, 1985, Plasmodium falciparum in vitro: diminished growth in hemoglobin H disease erythrocytes, Blood, 65, 452, 10.1182/blood.V65.2.452.452 · DOI
  13. K Chotivanich, 2002, Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria, Blood, 100, 1172, 10.1182/blood.V100.4.1172.h81602001172_1172_1176 · DOI
  14. CR Brockelman, 1987, Thalassemic erythrocytes inhibit in vitro growth of Plasmodium falciparum, J Clin Microbiol, 25, 56, 10.1128/JCM.25.1.56-60.1987 · DOI
  15. G Pasvol, 1978, Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria, Nature, 274, 701, 10.1038/274701a0 · DOI
  16. G Pasvol, 1980, The interaction between sickle haemoglobin and the malarial parasite Plasmodium falciparum, Trans R Soc Trop Med Hyg, 74, 701, 10.1016/0035-9203(80)90182-0 · DOI
  17. MJ Friedman, 1979, The role of hemoglobins C, S, and Nbalt in the inhibition of malaria parasite development in vitro, Am J Trop Med Hyg, 28, 777, 10.4269/ajtmh.1979.28.777 · DOI
  18. JA Olson, 1986, Synchronized cultures of P falciparum in abnormal red cells: the mechanism of the inhibition of growth in HbCC cells, Blood, 67, 997, 10.1182/blood.V67.4.997.997 · DOI
  19. RM Fairhurst, 2003, Aberrant development of Plasmodium falciparum in hemoglobin CC red cells: implications for the malaria protective effect of the homozygous state, Blood, 101, 3309, 10.1182/blood-2002-10-3105 · DOI
  20. RL Nagel, 1981, Impairment of the growth of Plasmodium falciparum in HbEE erythrocytes, J Clin Invest, 68, 303, 10.1172/JCI110248 · DOI
  21. G Pasvol, 1976, Fetal haemoglobin and malaria, Lancet, 1, 1269, 10.1016/S0140-6736(76)91738-4 · DOI
  22. MJ Friedman, 1979, Oxidant damage mediates variant red cell resistance to malaria, Nature, 280, 245, 10.1038/280245a0 · DOI
  23. G Pasvol, 1977, Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum, Nature, 270, 171, 10.1038/270171a0 · DOI
  24. RJ Wilson, 1977, Invasion and growth of Plasmodium falciparum in different types of human erythrocyte, Bull World Health Organ, 55, 179
  25. L Luzzatto, 1970, Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait, Lancet, 1, 319, 10.1016/S0140-6736(70)90700-2 · DOI
  26. EF Roth Jr, 1978, Sickling rates of human AS red cells infected in vitro with Plasmodium falciparum malaria, Science, 202, 650, 10.1126/science.360396 · DOI
  27. MJ Friedman, 1978, Erythrocytic mechanism of sickle cell resistance to malaria, Proc Natl Acad Sci U S A, 75, 1994, 10.1073/pnas.75.4.1994 · DOI
  28. SY Chen, 2008, The genomic analysis of erythrocyte microRNA expression in sickle cell diseases, PLoS One, 3, e2360, 10.1371/journal.pone.0002360 · DOI · Paper page
  29. C Sangokoya, 2010, microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease, Blood, 116, 4338, 10.1182/blood-2009-04-214817 · DOI
  30. G Lamonte, 2012, Translocation of sickle cell erythrocyte microRNAs into Plasmodium falciparum inhibits parasite translation and contributes to malaria resistance, Cell Host Microbe, 12, 187, 10.1016/j.chom.2012.06.007 · DOI · Paper page
  31. DI Baruch, 1996, Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1, Proc Natl Acad Sci U S A, 93, 3497, 10.1073/pnas.93.8.3497 · DOI · Paper page
  32. J Carlson, 1990, Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies, Lancet, 336, 1457, 10.1016/0140-6736(90)93174-N · DOI
  33. DK Kaul, 1991, Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions, Blood, 78, 812, 10.1182/blood.V78.3.812.812 · DOI
  34. JD Smith, 1995, Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes, Cell, 82, 101, 10.1016/0092-8674(95)90056-X · DOI · Paper page
  35. DI Baruch, 1995, Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes, Cell, 82, 77, 10.1016/0092-8674(95)90054-3 · DOI
  36. C Raventos-Suarez, 1985, Membrane knobs are required for the microcirculatory obstruction induced by Plasmodium falciparum-infected erythrocytes, Proc Natl Acad Sci U S A, 82, 3829, 10.1073/pnas.82.11.3829 · DOI
  37. A Salanti, 2003, Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria, Mol Microbiol, 49, 179, 10.1046/j.1365-2958.2003.03570.x · DOI · Paper page
  38. JA Rowe, 1997, P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1, Nature, 388, 292, 10.1038/40888 · DOI
  39. J Carlson, 1992, Plasmodium falciparum erythrocyte rosetting is mediated by promiscuous lectin-like interactions, J Exp Med, 176, 1311, 10.1084/jem.176.5.1311 · DOI
  40. Q Chen, 1998, Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum, J Exp Med, 187, 15, 10.1084/jem.187.1.15 · DOI
  41. L Schofield, 1993, Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites, J Exp Med, 177, 145, 10.1084/jem.177.1.145 · DOI
  42. TM Lopera-Mesa, 2012, Plasma Uric Acid Levels Correlate with Inflammation and Disease Severity in Malian Children with Plasmodium falciparum Malaria, PLoS One, 7, e46424, 10.1371/journal.pone.0046424 · DOI
  43. MC D'Ombrain, 2007, Plasmodium falciparum erythrocyte membrane protein-1 specifically suppresses early production of host interferon-gamma, Cell Host Microbe, 2, 130, 10.1016/j.chom.2007.06.012 · DOI
  44. R Udomsangpetch, 1993, Alteration in cytoadherence and rosetting of Plasmodium falciparum-infected thalassemic red blood cells, Blood, 82, 3752, 10.1182/blood.V82.12.3752.3752 · DOI
  45. RM Fairhurst, 2005, Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria, Nature, 435, 1117, 10.1038/nature03631 · DOI
  46. C Amaratunga, 2011, A role for fetal hemoglobin and maternal immune IgG in infant resistance to Plasmodium falciparum malaria, PLoS One, 6, e14798, 10.1371/journal.pone.0014798 · DOI
  47. MA Krause, 2012, alpha-Thalassemia impairs the cytoadherence of Plasmodium falciparum-infected erythrocytes, PLoS One, 7, e37214, 10.1371/journal.pone.0037214 · DOI
  48. RM Fairhurst, 2012, Abnormal PfEMP1/knob display on Plasmodium falciparum-infected erythrocytes containing hemoglobin variants: fresh insights into malaria pathogenesis and protection, Microbes Infect, 14, 851, 10.1016/j.micinf.2012.05.006 · DOI
  49. M Cyrklaff, 2011, Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes, Science, 334, 1283, 10.1126/science.1213775 · DOI
  50. L Schofield, 2005, Immunological processes in malaria pathogenesis, Nat Rev Immunol, 5, 722, 10.1038/nri1686 · DOI
  51. IA Clark, 2004, Pathogenesis of malaria and clinically similar conditions, Clin Microbiol Rev, 17, 509, 10.1128/CMR.17.3.509-539.2004 · DOI
  52. NH Hunt, 2003, Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria, Trends Immunol, 24, 491, 10.1016/S1471-4906(03)00229-1 · DOI
  53. CC John, 2010, Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria, Expert Rev Anti Infect Ther, 8, 997, 10.1586/eri.10.90 · DOI
  54. AH Achtman, 2012, Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria, Sci Transl Med, 4, 135ra164, 10.1126/scitranslmed.3003515 · DOI
  55. C Casals-Pascual, 2009, Can erythropoietin be used to prevent brain damage in cerebral malaria?, Trends Parasitol, 25, 30, 10.1016/j.pt.2008.10.002 · DOI
  56. JB Weinberg, 2008, Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria, Curr Opin Infect Dis, 21, 468, 10.1097/QCO.0b013e32830ef5cf · DOI
  57. O Takeuchi, 2010, Pattern recognition receptors and inflammation, Cell, 140, 805, 10.1016/j.cell.2010.01.022 · DOI · Paper page
  58. P Villa, 2003, Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis, J Exp Med, 198, 971, 10.1084/jem.20021067 · DOI
  59. AL Siren, 2001, Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress, Proc Natl Acad Sci U S A, 98, 4044, 10.1073/pnas.051606598 · DOI
  60. FA Wagener, 2001, Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase, Blood, 98, 1802, 10.1182/blood.V98.6.1802 · DOI
  61. MH Kapturczak, 2004, Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse, Am J Pathol, 165, 1045, 10.1016/S0002-9440(10)63365-2 · DOI · Paper page
  62. H Kim, 2011, Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics, Curr Opin Hematol, 18, 177, 10.1097/MOH.0b013e328345a4cf · DOI
  63. SH Koh, 2009, Erythropoietin increases the motility of human bone marrow-multipotent stromal cells (hBM-MSCs) and enhances the production of neurotrophic factors from hBM-MSCs, Stem Cells Dev, 18, 411, 10.1089/scd.2008.0040 · DOI
  64. Z Erbayraktar, 2009, Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing, Mol Med, 15, 235, 10.2119/molmed.2009.00051 · DOI
  65. G Krishnegowda, 2005, Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity, J Biol Chem, 280, 8606, 10.1074/jbc.M413541200 · DOI
  66. P Parroche, 2007, Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9, Proc Natl Acad Sci U S A, 104, 1919, 10.1073/pnas.0608745104 · DOI
  67. M Jaramillo, 2004, Hemozoin-inducible proinflammatory events in vivo: potential role in malaria infection, J Immunol, 172, 3101, 10.4049/jimmunol.172.5.3101 · DOI
  68. AK Tripathi, 2009, Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium, Blood, 114, 4243, 10.1182/blood-2009-06-226415 · DOI
  69. IA Clark, 1987, Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole, J Immunol, 139, 3493, 10.4049/jimmunol.139.10.3493 · DOI
  70. K Kaiser, 2006, Recombinant human erythropoietin prevents the death of mice during cerebral malaria, J Infect Dis, 193, 987, 10.1086/500844 · DOI
  71. TW Yeo, 2008, Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria, Proc Natl Acad Sci U S A, 105, 17097, 10.1073/pnas.0805782105 · DOI
  72. AL Conroy, 2010, Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study, PLoS One, 5, e15291, 10.1371/journal.pone.0015291 · DOI
  73. FE Lovegrove, 2009, Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children, PLoS One, 4, e4912, 10.1371/journal.pone.0004912 · DOI
  74. IA Clark, 2003, Induction of HO-1 in tissue macrophages and monocytes in fatal falciparum malaria and sepsis, Malar J, 2, 41, 10.1186/1475-2875-2-41 · DOI
  75. C Casals-Pascual, 2008, High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria, Proc Natl Acad Sci U S A, 105, 2634, 10.1073/pnas.0709715105 · DOI
  76. E Seixas, 2009, Heme oxygenase-1 affords protection against noncerebral forms of severe malaria, Proc Natl Acad Sci U S A, 106, 15837, 10.1073/pnas.0903419106 · DOI · Paper page
  77. BK Lopansri, 2003, Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production, Lancet, 361, 676, 10.1016/S0140-6736(03)12564-0 · DOI
  78. TW Yeo, 2007, Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria, J Exp Med, 204, 2693, 10.1084/jem.20070819 · DOI
  79. MR Hobbs, 2002, A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children, Lancet, 360, 1468, 10.1016/S0140-6736(02)11474-7 · DOI
  80. KA Rockett, 1991, Killing of Plasmodium falciparum in vitro by nitric oxide derivatives, Infect Immun, 59, 3280, 10.1128/IAI.59.9.3280-3283.1991 · DOI
  81. KA Rockett, 1994, Possible role of nitric oxide in malarial immunosuppression, Parasite Immunol, 16, 243, 10.1111/j.1365-3024.1994.tb00346.x · DOI
  82. R De Caterina, 1995, Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines, J Clin Invest, 96, 60, 10.1172/JCI118074 · DOI
  83. S Serirom, 2003, Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow, Am J Pathol, 162, 1651, 10.1016/S0002-9440(10)64299-X · DOI
  84. TN Williams, 2005, An immune basis for malaria protection by the sickle cell trait, PLoS Med, 2, e128, 10.1371/journal.pmed.0020128 · DOI
  85. L Gong, 2012, Evidence for both innate and acquired mechanisms of protection from Plasmodium falciparum in children with sickle cell trait, Blood, 119, 3808, 10.1182/blood-2011-08-371062 · DOI
  86. S Cohen, 1961, Gamma-globulin and acquired immunity to human malaria, Nature, 192, 733, 10.1038/192733a0 · DOI
  87. R Cornille-Brogger, 1979, Abnormal haemoglobins in the Sudan savanna of Nigeria. II. Immunological response to malaria in normals and subjects with sickle cell trait, Ann Trop Med Parasitol, 73, 173, 10.1080/00034983.1979.11687244 · DOI
  88. SJ Allen, 1992, Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia, Trans R Soc Trop Med Hyg, 86, 494, 10.1016/0035-9203(92)90083-O · DOI
  89. JY Le Hesran, 1999, Longitudinal study of Plasmodium falciparum infection and immune responses in infants with or without the sickle cell trait, Int J Epidemiol, 28, 793, 10.1093/ije/28.4.793 · DOI
  90. AJ Luty, 2000, Antibody responses to Plasmodium falciparum: evolution according to the severity of a prior clinical episode and association with subsequent reinfection, Am J Trop Med Hyg, 62, 566, 10.4269/ajtmh.2000.62.566 · DOI
  91. G Cabrera, 2005, The sickle cell trait is associated with enhanced immunoglobulin G antibody responses to Plasmodium falciparum variant surface antigens, J Infect Dis, 191, 1631, 10.1086/429832 · DOI
  92. F Verra, 2007, Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria, PLoS One, 2, e978, 10.1371/journal.pone.0000978 · DOI
  93. X Tan, 2011, Hemoglobin S and C heterozygosity enhances neither the magnitude nor breadth of antibody responses to a diverse array of Plasmodium falciparum antigens, J Infect Dis, 204, 1750, 10.1093/infdis/jir638 · DOI
  94. A Celada, 1982, Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes, Clin Exp Immunol, 47, 635
  95. GA Luzzi, 1991, Surface antigen expression on Plasmodium falciparum-infected erythrocytes is modified in alpha- and beta-thalassemia, J Exp Med, 173, 785, 10.1084/jem.173.4.785 · DOI
  96. TN Williams, 2002, The membrane characteristics of Plasmodium falciparum-infected and -uninfected heterozygous alpha(0)thalassaemic erythrocytes, Br J Haematol, 118, 663, 10.1046/j.1365-2141.2002.03610.x · DOI
  97. K Ayi, 2004, Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait, Blood, 104, 3364, 10.1182/blood-2003-11-3820 · DOI
  98. J Langhorne, 2008, Immunity to malaria: more questions than answers, Nature Immunol, 9, 725, 10.1038/ni.f.205 · DOI
  99. BC Urban, 2001, Peripheral blood dendritic cells in children with acute Plasmodium falciparum malaria, Blood, 98, 2859, 10.1182/blood.V98.9.2859 · DOI
  100. H Xu, 2002, The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection, J Exp Med, 195, 881, 10.1084/jem.20011174 · DOI
  101. T Sun, 2012, A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria, Proc Natl Acad Sci U S A, 109, E2117, 10.1073/pnas.1206573109 · DOI · Paper page
  102. MN Wykes, 2005, Plasmodium yoelii can ablate vaccine-induced long-term protection in mice, J Immunol, 175, 2510, 10.4049/jimmunol.175.4.2510 · DOI
  103. BC Urban, 1999, Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells, Nature, 400, 73, 10.1038/21900 · DOI
  104. Y Wu, 2011, Amplification of P. falciparum Cytoadherence through induction of a pro-adhesive state in host endothelium, PLoS One, 6, e24784, 10.1371/journal.pone.0024784 · DOI
  105. R Santiyanont, 1981, Red cells containing hemoglobin E do not inhibit malaria parasite development in vitro, Am J Trop Med Hyg, 30, 541, 10.4269/ajtmh.1981.30.541 · DOI

Cited by

Sorted by citations

Metadata

Authors
Taylor, S. M., Cerami, C., & Fairhurst, R. M.
Venue
PLoS Pathogens
Publisher
Public Library of Science (PLoS)
Published
2013-05-16
Volume
9
Issue
5
Pages
e1003327
ISSN
1553-7374
DOI
10.1371/journal.ppat.1003327
PMC
PMC3656091
Cited by
103
References
9
Language
en
Licence
creativecommons.org/publicdomain/zero/1.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review